• 1. Enabling non-flammable Li-metal batteries via electrolyte functionalization and interface engineering?
  Jing Yu,Yu-Qi Lyu,Jiapeng Liu,Mohammed B. Effat,Junxiong Wu J. Mater. Chem. A, 2019,7, 17995-18002
• 2. Enabling chloride salts for thermal energy storage: implications of salt purity?
  J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608
• 3. Excited-state proton-coupled electron transfer within ion pairs?
  Gerald J. Meyer,Leif Hammarstr?m Chem. Sci., 2020,11, 3460-3473
• 4. Evidence of field induced slow magnetic relaxation in cis-[Co(hfac)2(H2O)2] exhibiting tri-axial anisotropy with a negative axial component?
  Denis V. Korchagin,Elena A. Yureva,Alexander V. Akimov,Eugenii Ya. Misochko,Gennady V. Shilov,Artem D. Talantsev,Roman B. Morgunov,Alexander A. Shakin,Sergey M. Aldoshin,Boris S. Tsukerblat Dalton Trans., 2017,46, 7540-7548
• 5. Ester-directed orthogonal dual C–H activation and ortho aryl C–H alkenylation via distal weak coordination?
  Manickam Bakthadoss,Tadiparthi Thirupathi Reddy,Vishal Agarwal,Duddu S. Sharada Chem. Commun., 2022,58, 1406-1409

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Ketones
• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Carbonyl compounds Ketones

Methyl 4-(4-fluorophenyl)-4-oxobutanoate (CAS No. 39560-31-1): A Comprehensive Overview in Modern Chemical Biology

Methyl 4-(4-fluorophenyl)-4-oxobutanoate (CAS No. 39560-31-1) is a significant compound in the realm of chemical biology, exhibiting a unique structural framework that has garnered considerable attention from researchers worldwide. This compound, characterized by its ester functionality and fluorinated aromatic ring, serves as a versatile intermediate in synthetic chemistry and a potential candidate for pharmacological investigations.

The molecular structure of Methyl 4-(4-fluorophenyl)-4-oxobutanoate consists of a butanoic acid backbone modified with an ester group at the terminal carbon and a 4-fluorophenyl substituent attached to the fourth carbon. This configuration imparts distinct electronic and steric properties, making it an attractive building block for designing novel molecules with tailored biological activities. The presence of the fluorine atom, in particular, is a critical feature that influences both the reactivity and the metabolic stability of the compound.

In recent years, there has been a surge in research focusing on fluorinated compounds due to their enhanced binding affinity and improved pharmacokinetic profiles in drug development. The incorporation of fluorine into pharmaceuticals has been widely recognized for its ability to modulate lipophilicity, metabolic stability, and immunogenicity. Consequently, derivatives of Methyl 4-(4-fluorophenyl)-4-oxobutanoate have been explored as potential candidates for various therapeutic applications.

One of the most compelling aspects of this compound is its utility in the synthesis of bioactive molecules. Researchers have leveraged its reactive sites to develop inhibitors targeting enzymes involved in critical biological pathways. For instance, studies have demonstrated its role in generating novel scaffolds for kinase inhibitors, which are pivotal in treating cancers and inflammatory diseases. The ester group in Methyl 4-(4-fluorophenyl)-4-oxobutanoate can be readily hydrolyzed or transesterified, allowing for further functionalization and diversification.

The fluorinated phenyl ring adds another layer of complexity to this compound, enabling selective interactions with biological targets. Fluorine's electron-withdrawing nature enhances the electrophilicity of adjacent functional groups, facilitating nucleophilic attacks that are essential for constructing complex molecular architectures. This property has been exploited in designing probes for imaging applications and in developing drugs with improved binding affinities.

Recent advancements in computational chemistry have further illuminated the potential of Methyl 4-(4-fluorophenyl)-4-oxobutanoate as a pharmacophore. Molecular docking studies have revealed its high binding affinity to certain protein targets, suggesting its suitability as a lead compound for drug discovery programs. These computational insights have guided experimental efforts, leading to the identification of promising derivatives with enhanced biological activity.

In addition to its synthetic utility, Methyl 4-(4-fluorophenyl)-4-oxobutanoate has been investigated for its role in material science applications. The unique combination of functional groups makes it an excellent precursor for polymers and coatings with tailored properties. Researchers have explored its incorporation into polymeric matrices to enhance thermal stability and mechanical strength, demonstrating its versatility beyond traditional pharmaceutical applications.

The growing interest in green chemistry has also prompted investigations into sustainable synthetic routes for producing Methyl 4-(4-fluorophenyl)-4-oxobutanoate. Catalytic methods have been developed to streamline its synthesis while minimizing waste generation. These eco-friendly approaches align with global efforts to promote sustainable practices in chemical manufacturing.

The future prospects of this compound are vast and multifaceted. Ongoing research aims to uncover new applications and optimize existing ones. As our understanding of molecular interactions deepens, it is anticipated that derivatives of Methyl 4-(4-fluorophenyl)-4-oxobutanoate will continue to play a pivotal role in advancing both therapeutic and material science domains.

• 898752-08-4( )
• 41310-80-9(ethyl 4-(4-fluorophenyl)-4-oxobutanoate)
• 63131-29-3(Methyl 4-fluorobenzoylacetate)
• 260246-17-1(methyl 3-(3-fluorophenyl)-3-oxopropanoate)
• 122115-57-5( )
• 122115-51-9(ETHYL 7-(4-FLUOROPHENYL)-7-OXOHEPTANOATE)
• 327189-51-5( )
• 898752-37-9(ethyl 5-(3,5-difluorophenyl)-5-oxopentanoate)
• 898752-34-6( )
• 898752-12-0(Ethyl 6-(3-fluorophenyl)-6-oxohexanoate)